Regeneron Pharmaceuticals, Inc.

REGN·NasdaqGS·Healthcare
Compare
930.67−42.69 (−4.39%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD
Pre-market934.31+3.64 (+0.39%)

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close973.36
Open989.90
Day range927.42991.73
52-week range591.52991.73
Off day high−6.16%
Off 52-week high−6.16%
Volume1.38M
Avg. volume (3M)766.16K
Market cap96.28B
EPS (TTM)45.24
Forward P/E13.16
P/E ratio (TTM)20.57
Dividend yield0.40% (3.76)
Beta (5Y)0.10
Shares outstanding101.63M
Short interest2.18% of float
Earnings dateOct 30, 2026 (est.)
Analyst target977.93
Profit margin28.51%

Against its peers

Compare in full ›
REGN 9995.HK ROIV 4593.T RPRX 214450.KQ
Market cap 96.28B 40.23B 27.61B 33.08B 39.04B 2.34T
P/E (TTM) 20.6 6.1 — 235.6 44.2 —
Forward P/E 13.2 46.7 -27.5 -8.6 11.6 —
Price/book 2.8 3.8 6.5 3.8 4.5 —
Dividend yield 0.40% — — — 1.39% 1.66%
1-year change +43.87% −19.94% +85.85% −46.41% +64.28% −56.00%
Today −4.39% +1.49% +6.08% −3.54% +1.75% +0.67%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.

Related companies

Compare ›

The businesses closest to Regeneron Pharmaceuticals's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
RemeGen Co., Ltd.9995.HK · Biotechnology 40.23B 71.300 +1.49%
Roivant Sciences Ltd.ROIV · Biotechnology 27.61B 38.23 +6.08%
Healios K.K.4593.T · Biotechnology 33.08B 245.00 −3.54%
Royalty Pharma plcRPRX · Biotechnology 39.04B 67.56 +1.75%
PharmaResearch Co., Ltd.214450.KQ · Biotechnology 2.34T 225,000.00 +0.67%
BrightGene Bio-Medical Technology Co., Ltd.688166.SS · Biotechnology 13.81B 31.70 +2.42%
Biocon LimitedBIOCON.BO · Biotechnology 591.88B 361.40 +5.06%
Krystal Biotech, Inc.KRYS · Biotechnology 9.21B 310.84 +1.90%

Also based in Tarrytown, New York, then elsewhere in New York.

Company Mkt cap Price Today
Prestige Consumer Healthcare Inc.PBH · Tarrytown, NY 2.52B 53.28 +7.55%
Citigroup Inc.C.BA · New York, NY 347.10T 69,900.00 +2.38%
Coinbase Global, Inc.COIN.BA · New York, NY 67.45T 9,435.00 +4.43%
The Bank of New York Mellon CorporationBNY.BA · New York, NY 43.07T 128,000.00 +2.58%
Verizon Communications Inc.VZ.BA · New York, NY 39.54T 19,080.00 +1.27%
Pfizer Inc.PFE.BA · New York, NY 36.68T 12,870.00 +2.63%
JPMorgan Chase & Co.JPM · New York, NYOdds 935.07B 352.11 +4.18%
Colgate-Palmolive CompanyCL.BA · New York, NY 14.28T 53,900.00 +1.60%

The stocks whose daily moves over the past year went most closely with Regeneron Pharmaceuticals's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
Vertex Pharmaceuticals IncorporatedVRTX · Correlation 0.45 139.20B 549.04 +3.44%
Royalty Pharma plcRPRX · Correlation 0.44 39.04B 67.56 +1.75%
Gilead Sciences, Inc.GILD · Correlation 0.44Odds 216.41B 174.48 +4.19%
Incyte CorporationINCY · Correlation 0.39 25.04B 122.85 +4.47%
Biogen Inc.BIIB · Correlation 0.37 37.61B 254.46 +2.22%
Pfizer Inc.PFE.BA · Correlation 0.32 36.68T 12,870.00 +2.63%
Moderna, Inc.MRNA · Correlation 0.31Odds 103.15B 258.38 +13.11%

What visitors to Regeneron Pharmaceuticals's page also look at.

Company Mkt cap Price Today
Vertex Pharmaceuticals IncorporVRTX 139.20B 549.04 +3.44%
Biogen Inc.BIIB 37.61B 254.46 +2.22%
Gilead Sciences, Inc.GILDOdds 216.41B 174.48 +4.19%
Illumina, Inc.ILMN 34.25B 226.54 −4.90%
Incyte CorporationINCY 25.04B 122.85 +4.47%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All REGN news ›
Trefis·Negative

Is Regeneron Stock Riskier Than It Looks?

Regeneron’s EYLEA Faces More Biosimilar Rivals That medicine is EYLEA. Its rivals are biosimilars, which are copies of a biologic drug made by other drugmakers. On the October 30 call, management said the retinal franchise of EYLEA and…

REGNSNYLLY
Trefis·

Is Regeneron Stock Increasing Your Market Risk?

If you hold Regeneron Pharmaceuticals (REGN) or plan to, its 19.0% rise from October 26 to November 2, 2026, while the S&P 500 fell 1.8%, likely caught your eye. Your other money probably already follows the market, so how Regeneron…

REGNSNY
Trefis·Positive

Was There Any Sign Regeneron Stock Would Run?

An investor who bought a $10,000 stake in Regeneron Pharmaceuticals (REGN) at the October 31, 2025 close held about $15,010 on November 3, 2026. The company’s sales growth picked up over those twelve months. Management says most of the…

REGNSNY

From the 4Search news index, newest first.

In the news

316mentions in 30 days
86with it in the headline
Positivesentiment

Mentioned with

Regeneron294Regeneron Pharmaceuticals, Inc.250Regeneron Pharmaceuticals, Inc244Sanofi224Hagens Berman Sobol Shapiro Llp124TD Cowen99Regeneron-Sanofi Alliance87Alliance75

People in the coverage

Yancopoulos177Libtayo175Benzinga128Hagens Berman128Reed Kathrein126Dupixent123

Themes

Healthcare13375886F1077PR Newswire77Sny75Il-1374Finanzen69Sanofi69Biotechnology65

Most coverage from

  1. marketscreener.com62
  2. marketbeat.com24
  3. tradingview.com22
  4. seekingalpha.com19
  5. themarketsdaily.com16

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance